Published on 12/10/2017 12:10:38 PM | Source: Dion Global Solutions Ltd
Sun Pharma rises over 4% on getting EIR from USFDA
Shares of Sun Pharmaceutical Industries surges over 4 per cent on the Bombay Stock Exchange after the drug maker said that it has received Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for its Dadra plant. Buoyed by the development, shares of the company gained as much as 4.22 per cent to trade at intra-day high of Rs 548.00 apiece on the Bombay Stock Exchange.
In a similar fashion, shares of the company were trading 1.61 per cent higher at Rs 534.50 apiece on the National Stock Exchange. Meanwhile, the broader benchmark BSE Sensex was trading at 31,937.84, up 103.85 points, or 0.33 per cent, at 11:22 hours.